ZVRA
ZVRA clinical trials: ZEVRA THERAPEUTICS, INC.
Every trial on ClinicalTrials.gov where ZEVRA THERAPEUTICS, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 5
- Trials linked
- 3
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ZVRA on the catalyst calendar · ZVRA registry changes
- Primary completion Feb 28, 2024ActualPhase 2NCT05668754Study of SDX in Patients With Idiopathic Hypersomnia (IH)Zevra Therapeutics · Idiopathic HypersomniaCompletedZVRALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 20, 2019ActualPhase 3NCT03460652KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHDZevra Therapeutics · ADHDCompletedZVRALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 16, 2018ActualPhase 3NCT03292952KP415 Classroom Study in Children (6-12 Years of Age) With ADHDZevra Therapeutics · ADHDCompletedZVRALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2028Sponsor estimatePhase 2NCT06773026Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase...Jerry Vockley, MD, PhD · Medium-chain Acyl-CoA Dehydrogenase DeficiencyRecruitingZVRACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2027Sponsor estimatePhase 1NCT07125066An Individual Patient, Open Label Study to Use ACER-001 to Treat Combined D,L-2 Hydroxyglutaric Aciduria (C-2HGA)Jerry Vockley, MD, PhD · Combined D,L-2-hydroxyglutaric AciduriaEnrolling by invitationZVRACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 5 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner